We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Slams CBO for Comments On Generic Drug Reimbursements
GPhA Slams CBO for Comments On Generic Drug Reimbursements
January 10, 2006
The Generic Pharmaceutical Association (GPhA) recently took the Congressional Budget Office (CBO) to task for its recent letter to Sen. Charles Schumer (D-N.Y.), in which CBO downplayed potential consequences of raising the drug rebates paid by generic drug manufacturers to the Medicaid program.